Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. US Food and Drug Administration, ‘Guidance for industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims’. (2009 Dec). Accessed: 31 Oct 2022. [Online]. Available: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims
2. Weldring, T., & Smith, S. M. S. (2013). Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Services Insights, 6, 61–68. https://doi.org/10.4137/HSI.S11093
3. Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M. (2018). The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Related Outcome Measures, 9, 353–367. https://doi.org/10.2147/PROM.S156279
4. Au, H.-J., Ringash, J., Brundage, M., Palmer, M., Richardson, H., & Meyer, R. M. (2010). Added value of health-related quality of life measurement in cancer clinical trials: The experience of the NCIC CTG. Expert Review of Pharmacoeconomics & Outcomes Research, 10(2), 119–128. https://doi.org/10.1586/erp.10.15
5. Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D. (2016). Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. Journal of Clinical Oncology, 34(6), 557–565. https://doi.org/10.1200/JCO.2015.63.0830